In vitro drug causality assessment in Stevens–Johnson syndrome – alternatives for lymphocyte transformation test
Article first published online: 20 AUG 2013
© 2013 John Wiley & Sons Ltd
Clinical & Experimental Allergy
Volume 43, Issue 9, pages 1027–1037, September 2013
How to Cite
Clinical & Experimental Allergy, 2013; (43) 1027–1037., , , , , .
- Issue published online: 20 AUG 2013
- Article first published online: 20 AUG 2013
- Accepted manuscript online: 13 MAY 2013 08:40PM EST
- Manuscript Accepted: 8 MAY 2013
- Manuscript Revised: 7 MAY 2013
- Manuscript Received: 5 OCT 2012
|cea12145-sup-0001-FigS1-TableS1.doc||Word document||477K||Figure S1. Differences between conditions ‘with’ and without preincubation with IL-5 and IL-7, Comparison of granzyme B (GrB) and granulysin (Grl) expression in culprit drug stimulated cells in the patients group. Results are expressed as delta (Δ) values (the difference between the response in the presence of tested drugs minus the negative control). The Wilcoxon matched-pair signed rank test was applied. ELISpot, enzyme-linked immunospot assay; m, mean. Table S1. The summary of individual test results for all the tests undertaken in patients.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.